Clinical trial
A Single Arm, Open-Label Pivotal Contraceptive Efficacy Study of Ovaprene
NCT06127199 is registered in ClinicalTrials.gov with Daré Bioscience, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm, Open-Label Pivotal Contraceptive Efficacy Study of Ovaprene
- Lead sponsor
- Daré Bioscience, Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 19, 2023
- Completion date
- September 30, 2027
- Enrollment
- 656 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
contraception